Within the scope of the analyzed protein biomarkers, albumin, transferrin, and R–SH emerged as particularly promising indicators of disease activity, exhibiting significant decreases in levels among individuals with IBD compared to healthy controls. This evidence concerns the gene ALB and inflammatory bowel disease.